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Abstract
Abdominal aortic aneurysm (AAA) is a life-threatening immunological disease responsible
for 1 to 2% of all deaths in 65 year old or older individuals. Although mononuclear cell infil-
trates have been demonstrated in AAA lesions and autoimmunity may be responsible for
the initiation and account for the propagation of the disease, the information available about
the pathogenesis of AAA is limited. To examine whether AAA lesions from patients with
AAA contain clonally expanded α-chain TCR transcripts, we amplified by the non-palin-
dromic adaptor-PCR (NPA-PCR)/Vα-specific PCR and/or the Vα-specific PCR these α-
chain TCR transcripts. The amplified transcripts were cloned and sequenced. Substantial
proportions of identical α-chain TCR transcripts were identified in AAA lesions of 4 of 5
patients, demonstrating that clonally expanded T cells are present in these AAA lesions.
These results were statistically significant by the bimodal distribution. Three of 5 of these
patients were typed by DNA-based HLA-typing and all three expressed DRB1 alleles con-
taining the DRβGln70 amino acid residue that has been demonstrated to be associated with
AAA. All three patients exhibited clonally expanded T cells in AAA lesions. Four of the 5
patients with AAA who exhibited clonal expansions of α-chain TCR transcripts, also exhib-
ited clonal expansions of β-chain TCR transcripts in AAA lesions, as we have demonstrated
previously (J Immunol 192:4897, 2014). αβ TCR-expressing T cells infiltrating AAA lesions
contain T-cell clones which have undergone proliferation and clonal expansion in vivo in
response to as yet unidentified specific antigens that may be self or nonself. These results
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Check for 
updates 
provide additional evidence supporting the hypothesis that AAA is a specific antigen-driven
T-cell autoimmune disease.
Introduction
Abdominal aortic aneurysm (AAA) is a common immunological disease with a strong genetic
component diagnosed in 3% of 60 years old or older [1–6]. AAA accounts for 1–2% of deaths
of 65 years old or older men, and is the 13th cause of death of men and women in the US of all
ages [2]. AAA is characterized by dilations and enlargement of abdominal aorta with a diame-
ter>3 cm or >50% of normal arteries [7]. Mortality of ruptured AAA is 85–90% [7,8].
Our understanding of the pathogenesis of AAA is limited. Environmental and genetic fac-
tors are involved and AAA is a complex multifactorial disease [3–5,9]. Strong evidence demon-
strates that autoimmunity may be responsible for the pathogenesis of AAA and is summarized
in Table 1 [3–5,9,10].
Our findings of substantial proportions of identical β-chain TCR transcripts in AAA lesions
demonstrate the presence of clonally expanded T cells [10, 41]. These results are statistically
significant, can be explained only by proliferation and clonal expansion in vivo of T cell clones
in response to specific, as yet unidentified antigen(s) [10, 41], and strongly suggest that AAA is
a specific antigen driven T cell disease [10,41].
Two highly polymorphic polypeptides, the α- and the β- chain, are used by the TCR to rec-
ognize peptides in association with self-MHC, and are rearranged exclusively in T cells [42].
We have shown that clonally expanded β-chain TCR transcripts are present in AAA lesions
[10,41], however, this β-chain TCR clonality does not necessarily imply clonality of the α-
chain TCR. Experimental proof is needed. The α-chain TCR clonality and repertoire should
also be studied in AAA lesions for several reasons (Table 2).
Table 1. Evidence demonstrating that autoimmunity may be responsible for the pathogenesis of AAA.
References
T, B, and NK cells and monocyte/macrophages infiltrate AAA lesions. [10–12]
Mononuclear infiltrating cells express early (CD69), intermediate (CD38, CD25) and late
(CD45RO, HLA Class II) activation antigens revealing an ongoing immune response.
[10]
APCs are present in AAA lesions, often in physical contact with CD4+, CD8+ and B-lymphocytes. [3, 13, 14]
Pro-inflammatory Th1 cytokines (IFN-γ, IL-2, and others) play an important role in the
destruction of the aortic wall and the pathogenesis of AAA. Th2 cytokines are also present in AAA
lesions.
[3, 9, 15–17]
IgG autoantibody from AAA lesions recognize proteins present in normal aortic tissue. [18, 19]
AAA is associated with HLA class I (HLA-A2, HLA-B61) and class II (HLA-DRB1�02,
-DRB1�04).
[20–22]
Several putative AAA self-antigens have been identified including elastin and elastin fragments
microbial-associated glycoprotein-36, collagen types I and III, carbonic anhydrase and oxidized
low-density lipoprotein.
[3, 18, 19, 23–
30]
Several putative AAA nonself (microbial) antigens have also been identified, including Chlamydia
pneumonia, Treponema palladium and cytomegalovirus. Molecular mimicry may be responsible
for T-cell responses in AAA patients.
[31–36, 35, 37]
The frequency and the suppressor activity of CD4+CD25+FOXP3+ Tregs and the expression of
FOXP3 transcript/protein are significantly lower in AAA vs normal donors.
[38–40]
Substantial proportions of identical β-chain T-cell receptor (TCR) transcripts are present in AAA
lesions.
[10, 41]
https://doi.org/10.1371/journal.pone.0218990.t001
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We report here that T cells infiltrating AAA lesions from patients with AAA contain clon-
ally expanded α-chain TCR transcripts. Amplification of α-chain TCR transcripts from AAA
lesions by the non-palindromic adaptor-PCR (NPA-PCR)/Vα-specific PCR and/or the Vα-
specific PCR [41, 57–63] followed by cloning and sequencing demonstrated substantial pro-
portions of identical α-chain TCR transcripts suggesting the presence of oligoclonal T cells.
These results can be explained only by proliferation and clonal expansion of T-cell clones in
vivo in response to specific, although not yet identified, self or non-self antigen(s), that they
recognize.
Methods
Patients
The characteristics of the patients who provided AAA specimens for these studies are
shown in Table 3. AAA size, race, age, gender, recent and past history of cardiovascular risk
factors (high cholesterol, aortic valve replacement and current or ex-tobacco smoking) and
associated diseases (chronic obstructive pulmonary disease, chronic renal disease, coronary
artery disease, diabetes mellitus, and hypertension) are shown (Table 3). These patients
were undergoing surgery for infrarenal AAAs repair. Adherent blood clots were stripped
away from the aneurysm wall of these AAA specimens prior to use. Grossly normal infrare-
nal abdominal aortic specimens were obtained at autopsy from patients who died of non-
vascular causes and employed as normal controls. Human peripheral blood mononuclear
cells (PBMC) were employed as methodological control and were obtained from normal
donors. The studies reported here were reviewed and approved by the IRB of Temple Uni-
versity Hospital and by the IRB of the Advocate Lutheran General Hospital. Written
informed consent was obtained from the study participants. Procurement of additional
peripheral blood from normal donors to prepare PBMC (methodological control) was
approved by Old Dominion University.
Immunohistochemistry
AAA specimens were divided into two fractions. One was used for RNA preparation either
immediately (fresh) or it was snap frozen in liquid nitrogen and used at a later time. The other
Table 2. Reasons to study α-chain TCR clonality and repertoire in AAA lesions.
References
Both α- and β-chain TCR and in particular their CDR3s are critical in antigen recognition. [43–46]
MHC class I & II restriction is mostly controlled by α-chain CDR1 and CDR3. [42–49]
CD45RO- T cell clones specific for a single antigenic epitope employ a unique TCR β-chain and may
be paired on the average with 25 different TCR α-chains; CD45RO+ T-cell clones employ a TCR β-
chain paired only with a single TCR α-chain
[50–52]
T cells expressing invariant α-chain TCR, but non-invariant β-chain TCR have been reported.
Invariant natural killer T (NKT) cells utilize invariant α-chain TCR transcripts in both mice
(Vα14Jα18) and humans (Vα24Jα18) and a limited number non-invariant β-chain TCR transcripts
preferentially utilizing Vβ2 or Vβ7 (mice) and Vβ11 (humans).
[53, 54]
HLA Class II DRα of DR molecule is monomorphic, while DQα of DQ and DPα of DP molecules,
respectively, are polymorphic. HLA class II are close counterparts of TCR in antigen recognition.
[55]
HLA class I are comprised of a polymorphic α-chain and an invariant β2-microglobulin, which does
not involve directly in antigen recognition but supports structurally the α-chain.
[55]
Expression in appropriate T cells of clonally expanded α- and β-chain TCR in AAA lesions and
development of an antigen presentation system may permit the identification of putative AAA antigen
(s).
[56]
https://doi.org/10.1371/journal.pone.0218990.t002
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fraction was embedded in optimum cutting technology (OCT) formulation and it was snap
frozen in liquid nitrogen and stored, until used, at -70˚C for immunohistochemistry. Immu-
nostaining was performed as described [64–66], by the avidin-biotin complex (ABC)—immu-
noperoxidase method (Vector Labs, Burlingame, CA), using: (i) an anti-CD3 monoclonal
antibody (mab), clone NCL-CD3-PS1 (Novocastra, Newcastle upon Tyne, U.K.); (ii) an anti-
CD4 mab clone 4B12 (Dako Glustrop, Denmark); (iii) an anti-CD8 mab clone C8/144B
(Dako).
Isolation of PBMC from normal donors
PBMC were isolated from venous peripheral blood by a Ficoll-Hypaque density cushion [67].
DNA-based HLA-typing for HLA-DRB1, -DQA1 and -DQB1
DNA was prepared from AAA specimens for HLA-typing of DRB1, DQA1 and DQB1 loci as
previously described [68]. Typing at HLA-DRB1 (exon 2) and DQB1 (exons 2 and 3) using
AlleleSEQR typing reagents (Abbott Molecular, Des Plaines, IL). Typing at HLA-DQA1 was
carried out using sequence specific primers (SSP) typing (Invitrogen SSP-Unitrays, Carlsbad,
CA; Qiagen Olerup-SSP, Valencia, CA). Any remaining ambiguities of HLA-typing were
resolved using sequence specific primers (SSP) typing (Invitrogen SSP-Unitrays, Carlsbad,
CA; Qiagen Olerup-SSP, Valencia, CA). DNA sequencing was carried out using an ABI 3130
sequencer (Applied Biosystems, Carlsbad, CA). Results were analyzed by Assign-SBT v3.5
Software (Conexio Genomics, Fremantle, Australia).
RNA isolation
Total RNA was prepared from fresh (cryopreserved) AAA lesions containing tissue from these
patients using a guanidinium thiocyanate solution, as recommended by the manufacturer
(Stratagene, La Jolla, CA), and then treated with DNase from the Atlas pure total RNA labeling
system (Clontech Laboratories, Inc., Mountain View, CA) to eliminate potential genomic
DNA contamination.
Table 3. Characteristics of the patients with AAA�.
Patient Gender Race Age AAA size
(cm)
HTN COPD TOB CHOL DM Other
AAA00 M C 71 4.8 Y N N N N
AAA03 M C 80 5.5 Y N N Y N
AAA09 M C 78 7.4 Y Y N N N CAD/
CRI
AAA10 M C 78 7.9 N N N Y Y CAD
AAA12 M C 77 UN UN UN UN UN UN UN
M = 5 C = 5 Avg. = xx
n = 5
Avg. = xx n = 4
UN = 1
Yes = 3 No = 1
UN = 1
Yes = 1 No = 3
UN = 1
Yes = 0 No = 4
UN = 1
Yes = 2 No = 2
UN = 1
Yes = 1 No = 3
UN = 1
M: Male; UN: Unknown; C: Caucasian; Y: Yes; N: No.
HTN: Hypertension; COPD: Chronic obstructive Pulmonary Disease; TOB: Current or ex- tobacco smoker; CHOL: High cholesterol; DM: Diabetes mellitus; CAD:
Coronary artery disease; CRI: Chronic renal disease; AOVR: Aortic valve replacement.
� Reproduced in part, with the permission of The American Association of Immunologists, Inc., from Lu et al, J. Immunol., 192: 4897–4912, 2014 (reference [41]).
Copyright 2014. The American Association of Immunologists, Inc.
https://doi.org/10.1371/journal.pone.0218990.t003
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Synthesis of cDNA
cDNA was synthesized from oligo-(dT)15- NotI (Promega) primed total RNA. We employed a
SuperScript II (GibcoBRL) cDNA synthesis kit, according to the manufacturer’s specifications
[41,57–63]. Double-stranded cDNA was blunt-ended for efficient adaptor ligation by using T4
DNA polymerase.
Amplification by the nonpalindromic adaptor PCR (NPA-PCR)/Vα-
specific PCR
(i) Adaptor ligation and NotI digestion. Double-stranded blunt-ended cDNA was
ligated at the 5’ and 3’ blunt ends with an equivalent molar concentration of a nonpalindromic
adaptor (NPA) comprised of two complementary oligonucleotides pre-annealed to each other:
5’-AATTCGAACCCCTTCGAGAATGCG-3’ and 3’-GCTTGGGGAAGCTCTTACGC-p-5’
(S1 Table). cDNA and NPA were ligated for 14 hrs at 16˚C with T4 DNA ligase (Gibco-BRL).
The ligated adaptor was removed from the 3’ end of the double-stranded cDNA by NotI
restriction endonuclease digestion (2 hrs at 37˚C), while it was retained at the 5’ end [41,57–
63]. Digested cDNA was purified using a G-50 column as recommended (5’-3’, Boulder, Co).
(ii) First cycle amplification by NPA-PCR. This was carried out as described [41,57–63],
with minor modifications. The nonpalindromic adaptor 5’-AATTCGAACCCCTTCGAGA
TGCT-3’ oligonucleotide was employed as the 5’ amplification primer. A hCα3 oligonucleo-
tide located in the Cα region, 3’ of Jα, was employed as a 3’ amplification primer (S1 Table).
cDNA (20 μl), purified by a G-50 column, was amplified using NPA-PCR, in 100μl, containing
the cDNA, the amplification primers, 5 units of native pfu DNA polymerase and 1mM dNTPs
in 1xbuffer [41,57–63]. PCR was performed, as follows: 5 min at 95˚C for cDNA denaturation,
amplification by 30 cycles including 1 min at 94˚C (denaturation), 1 min at 45˚C (annealing),
2 min at 72˚C (elongation) and a final extension of 7 min at 72˚C. The amplified transcripts
were purified by a G-50 column, as recommended by the manufacturer.
(iii) Second cycle of amplification by individual Vα-specific PCR. Thirty two different
Vα-specific PCRs were performed. NPA-PCR amplified α-chain TCR cDNA (4 μl) was used
as a template in a reaction volume of 50 μl, which contained the cDNA, the amplification
primers, 2.5 units of native pfu DNA polymerase and 1mM dNTPs in 1xbuffer [41,57–63]. Sin-
gle oligonucleotides, each specific for one of 32 Vα families (S1 Table), were used in 32 sepa-
rate amplifications, as 5’ end amplification primer. A Cα 3’amplification primer designated as
hCα2 was used and it is located 5’ to the hCα3 primer employed for the first NPA-PCR ampli-
fication (nested design), 3’ of Jα (S1 Table). This nested design virtually eliminates possible
PCR amplification of members of the Ig supergene family that may share homology with the
α-chain TCR because it will be unlikely that these members will have substantial homology
with both hCα3 and hCα2 sites. The reaction mixture was denatured at 95˚C for 5 min, ampli-
fied by 30 PCR cycles at 94˚C for 1 min, 55˚C for 1 min, and 72˚C for 2 min followed by a 7
min final extension step at 72˚C.
Single Vα-specific PCR amplification
This was performed [41,57–63] to evaluate, in more detail, single Vα families or subfamilies or
to confirm clonal expansions identified by NPA-PCR/Vα-specific PCR. Template cDNA was
synthesized from total RNA isolated from the same AAA specimen employed for NPA-PCR/
Vα-specific PCR, or from total RNA prepared in separate experiments from the same AAA
specimen. Selection of the Vα families to be amplified by Vα-specific PCR was made on the
basis of the NPA-PCR/Vα-specific PCR findings. Vα5 and Vα24 (patient AAA03), Vα6, Vα9
Clonally expanded alpha-chain T-cell receptor (TCR) transcripts in Abdominal Aortic Aneurysm (AAA)
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and Vα12 (patient AAA09), Vα2 and Vα8 (patient AAA00) and Vα6 (patient AAA10) families
were amplified by Vα-specific PCR. Vα family specific oligonucleotides (S1 Table), were used
as 5’ end amplification primers. The hCα2 oligonucleotide was used as 3’amplification primer.
Vα-specific PCR (35 cycles), included denaturation (94˚C, 1 min), annealing (55˚C, 1 min),
elongation (72˚C, 2 min), and final extension (72˚C, 7 min).
Cloning of the PCR products
Eight μl from each one of the 32 NPA-PCR/Vα-specific PCR amplified products were mixed
together and incubated with Taq polymerase for 10 min at 72˚C to add an adenine at the 3’
end and the mixture was selected by agarose gel electrophoresis in respect to size and purified
using a Geneclean Kit (Bio101, Vista, CA), following the instructions of the manufacturer.
Mixing these PCR amplification products from each of the 32 Vα families before cloning and
sequencing, reduces substantially the work needed for these experiments [41,57–59]. Purified
NPA-PCR/Vα-specific PCR or Vα-specific PCR products were cloned into the TOPO-TA vec-
tor (Invitrogen, Carlsbad, CA), were transformed into Top10 One Shot Chemically competent
cells (Invitrogen) as described by the manufacturer and were submitted to blue-white screen-
ing. Top10 One Shot Chemically competent E.coli cells were incubated for 30–45 min with the
vector on ice and were subjected to heat shock for 30–45 sec at 42˚C. The competent cells were
incubated on ice for 2 min and 250 μl of SOC medium were added and incubated at 37˚C for 1
hr. The competent cells were plated in X-gal containing agar plates [41,57–63]. White colonies
were collected using the Perfectprep Plasmid Mini Kit (Eppendorf, Westbury, NY) following
the specifications of the manufacturer. Large numbers of white colonies were obtained.
The TCR repertoire is very large [47–49,69,70] and for this reason the probability is very
small to find by chance in an independent sample of T lymphocytes two identical copies of a
single α- or β-chain TCR transcript. The only mechanism that can explain the presence of
multiple identical copies of a single α- or β-chain TCR transcript in an independent popula-
tion of T lymphocytes is specific antigen-driven proliferation and clonal expansion (reviewed
in [56]). However, during transformation of DH5α-E. coli-competent cells the mixture of E.
coli cells and plasmid was heat shocked by treatment for 30 sec at 42˚C followed by growth in
SOC medium at 37˚C for 1 hr before the colonies were plated. In ideal growth conditions (log
phase growth) E. coli cells divide every 20 min and this could result in two divisions in one
hour [71]. Because of the heat shock treatment, the E. coli cells may not enter right away to the
logarithmic growth phase. However, it is possible, although unlikely, that few E. coli-trans-
formed cells may double before they are plated. Therefore, the appearance in two different col-
onies of an identical TCR transcript, designated as a doublet, may indicate a clonal expansion
or may be the result of a single E. coli cell transformed and divided (doubled) before it was
plated. We are addressing this issue in the statistical method that we are employing (see below;
second alternative hypothesis), although doubling of a transfected E. coli cell before plating is
rather infrequent. As a methodological control, to make certain that all PCR, cloning and
sequencing methods were performing correctly, we amplified by NPA-PCR/Vα-specific PCR
or NPA-PCR, cloned, and sequenced 125 α-chain TCR transcripts from PBMC of 3 normal
donors. An additional 45 α-chain TCR transcripts from PBMC of 2 normal donors were
reported previously (refs. [59] and [60]) (see below).
Sequencing
Plasmids were sequenced by the dideoxy chain termination method using 6% polyacrylamide
DNA sequencing gels and an ABI373A DNA Sequencer (Applied Biosystems, Foster City,
Clonally expanded alpha-chain T-cell receptor (TCR) transcripts in Abdominal Aortic Aneurysm (AAA)
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CA). Comparable numbers of α-chain TCR clones were obtained after NPA-PCR/Vα-specific
PCR amplification and cloning and as well as after Vα-specific PCR and cloning.
Computer analysis. Sequence comparison
Sequences of α-chain TCR transcripts were identified in AAA lesions or in PBMC from nor-
mal controls encoding for V, D, J and C regions by comparing them to those in the NCBI data-
bases by the standard nucleotide-nucleotide BLAST sequence alignment program [41,57–63].
The N region nucleotide sequence of TCR transcripts was identified as the nucleotide sequence
contained between the last identifiable Vα nucleotide and the first identifiable Jα nucleotide.
Deduced CDR3 region amino acid sequences were compared to those in the NCBI databases
using BLAST gapped BLAST and PSI BLAST protein database programs.
Statistical analysis
The binomial distribution was employed [41,58,59,62] to determine the probability, p, that the
number (x) of the multiple identical α-chain TCR transcripts identified among those
sequenced (x/n; n is the total number of α-chain TCR transcripts sequenced), was statistically
significant versus (i) a first alternative hypothesis that each α-chain TCR transcript is expressed
only once and all α-chain TCR transcripts sequenced when compared to each other are unique
(1/n), or (ii) a second alternative hypothesis that only a single α-chain TCR transcript is
expressed twice and all the remaining α-chain TCR transcripts identified are expressed only
once (2/n) [41]. The first alternative and the second alternative hypotheses were initially devel-
oped [41] for the analysis of β-chain TCR, and their use is extended here to the analysis of α-
chain TCR.
Results
Multiple identical copies of α-chain TCR transcripts are present in AAA
lesions
Immunohistochemical staining of AAA tissues with the anti-CD3 mab revealed the presence
of substantial CD3+ T-cell infiltrates in these AAA lesions which were predominant in the
adventitia and media [10, 41]. Staining with the appropriate mabs revealed that these infiltrates
contained both CD4+ and CD8+ T lymphocytes [41]. These results have been shown previ-
ously [10,41] and they are in agreement with the reports of others [11–14]. Rare, if any, mono-
nuclear cell infiltrates are found in grossly normal autopsy infrarenal abdominal aortic tissue
which was obtained from patients who died of nonvascular causes [41].
Multiple identical copies of α-chain TCR transcripts were found in AAA lesions from
patients with AAA by PCR amplification, cloning and sequencing. Comparison of these
sequences to those of the GenBank database using BLAST revealed that they were novel (not
reported in the GenBank) and typical of productively rearranged human α-chain TCR tran-
scripts. Statistically significant, by the binomial distribution, α-chain TCR clonal expansions
were identified in AAA lesions in 4 of 5 patients with AAA.
Sequence analysis of α-chain TCR transcripts from AAA lesions from patient AAA03 after
NPA-PCR/Vα-specific PCR amplification followed by cloning and sequencing revealed several
clonal expansions (Table 4): (i) Clone aaa03npa04 accounted for 5 of 57 identical transcripts
(9%) (Vα5.1Jα3) (CDR3: LE). These results are statistically significant by the bimodal distribu-
tion. Probability (p) of appearance of 5 of 57 identical α-chain TCR transcripts by chance
against the alternative hypothesis that each α-chain TCR transcript is expressed only once 1/
n = 1/57, was p = 0.003. The p of the appearance of 5 of 57 identical α-chain TCR transcripts
Clonally expanded alpha-chain T-cell receptor (TCR) transcripts in Abdominal Aortic Aneurysm (AAA)
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Table 4. α-chain TCR transcripts (CDR3 region) expressed in aneurysmal wall of patients with AAA.
Clone Vα N Jα Transcript Frequency in
Specimen
p value
PATIENT AAA03
α-chain TCR transcripts amplified by NPA- PCR/Vα-specific PCR vs.
1/57
vs.
2/57
aaa03npa04 C A L E G Y S S Vα5.1Jα3 p = 0.003 p = 0.034
tgtgct ctaga ggggtacagcagt 5/57(9%)
aaa03npa21 C V V S A G R E Y G N K L Vα24.1Jα47 p = 0.003 p = 0.034
tgtgtggtgagc gcgggtag ggaatatggaaacaaactg 5/57(9%)
aaa03npa09 C A Y I S G N K L Vα14.1Jα47 p = 0.015 p = 0.089
tgtgcttat atctc tggaaacaaactg 4/57(7%)
aaa03npa33 C A M R E G E G G S N Y K L Vα6.1Jα54 p = 0.015 p = 0.089
tgtgcaatgaga gagggcgag ggaggtagcaactataaactg 4/57(7%)
aaa03npa16 C A V E E T S G S R L Vα13.1Jα58 p = 0.06 p = 0.183
tgtgctgtg g aagaaaccagtggctctaggttg 3/57(5%)
aaa03npa02 C A G Q K G G T S Y G K L Vα25.1Jα53 p = 0.06 p = 0.183
tgtgctggg cagaag ggtggtactagctatggaaagctg 3/57(5%)
aaa03npa19 C A V E T G F Q K L Vα11.1Jα8 ns ns
tgtgctgtggag acc ggctttcagaaactt 2/57(4%)
aaa03npa12 C A V V R N N N D R L Vα13.1Jα31 ns ns
tgtgctgtc gttc ggaataacaatgacagactc 2/57(4%)
aaa03npa10 C A V V T S V G S G N T G K L Vα13.1Jα37 ns ns
tgtgctgtg gtcactagcgt tggctctggcaacacaggcaaacta 2/57(4%)
aaa03npa26 C A V A K D G G S Q G N L Vα13.1Jα42 ns ns
tgtgctgtg gcaaagg atggaggaagccaaggaaatctc 2/57(4%)
aaa03npa11 C A V E G S S G D K L Vα13.1Jα46 ns ns
tgtgctgtg gaggg aagcagcggagacaagctg 2/57(4%)
aaa03npa20 S A V Y P S P V A G G G N K L Vα21.1Jα10 ns ns
tctgcagtgtac ccatctcccgtcg cgggaggaggaaacaaactc 2/57(4%)
aaa03npa27 C A T D S F V Y S N A S K I Vα3.1Jα3 ns ns
tgtgctacg gactctttcgtttacagcaa tgcttccaagata 1/57(2%)
aaa03npa61 C A T A R M D S S Y K L Vα3.1Jα12 ns ns
tgtgctacg gccc ggatggatagcagctataaattg 1/57(2%)
aaa03npa36 C A T D A N D Y K L Vα3.1Jα20 ns ns
tgtgctacg gacgca aacgactacaagctc 1/57(2%)
Remaining 18 of 57 sequences are unique when compared to each other and are shown in the supporting information section, S2 Table.
α-chain TCR transcripts amplified by single Vα5-specific PCR vs.
1/20
vs.
2/20
aaa03npa04 C A L E G Y S S A S K I Vα5.1Jα3 p<0.0001 p<0.0001
tgtgct ctaga ggggtacagcagtgcttccaagata 20/20(100%)
α-chain TCR transcripts amplified by single Vα24-specific PCR vs.
1/22
vs.
2/22
aaa03npa21 C V V S A G R E Y G N K L Vα24.1Jα47 p<0.0001 p<0.0001
tgtgtggtgagc gcgggtag ggaatatggaaacaaactg 13/22(59%)
aaa03va2401 C V V S S G G S Y I Vα24.1Jα6 p = 0.0003 p = 0.0092
tgtgtggtgagc tcaggaggaagctacata 6/22(27%)
aaa03va2408 C V A A T G G F K T Vα24.1Jα9 p = 0.06 p = 0.189
tgtgtg gcggc tactggaggcttcaaaact 3/22(14%)
PATIENT AAA09
(Continued)
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Table 4. (Continued)
Clone Vα N Jα Transcript Frequency in
Specimen
p value
α-chain TCR transcripts amplified by NPA-PCR/Vα-specific PCR vs.
1/36
vs.
2/36
aaa09npa08 C A L S E P F Q T G A N N L Vα12.1Jα36 p = 0.06 p = 0.187
tgtgctctgagt gagccttt tcaaactggggcaaacaacctc 3/36(8%)
aaa09npa16 C A L S R G S Q G N L Vα9.1Jα42 p = 0.06 p = 0.187
tgtgctctg tcta gaggaagccaaggaaatctc 3/36(8%)
aaa09npa01 C A M R E G D Q A G T A L Vα6.1Jα15 ns ns
tgtgcaatgaga gagggag accaggcaggaactgctctg 2/36(8%)
aaa09npa37 C A M R E I R T S Y D K V Vα6.1Jα50 ns ns
tgtgcaatgaga gagattcgg acctcctacgacaaggtg 2/36(6%)
aaa09npa22 C A L R G L N Q A G T A L Vα9.1Jα15 ns ns
tgtgctcta aggggtctc aaccaggcaggaactgctctg 2/36(6%)
aaa09npa39 C A L A P S G N T G K L Vα5.1Jα37 ns ns
tgtgctcta gcccc ctctggcaacacaggcaaacta 1/36(3%)
aaa09npa26 C A M R S N T G F Q K L Vα6.1Jα8 ns ns
tgtgcaatgaga tc gaacacaggctttcagaaactt 1/36(3%)
aaa09npa09 C A M R E G M A G F Q K L Vα6.1Jα8 ns ns
tgtgcaatgaga gagggcatgg caggctttcagaaactt 1/36(3%)
Remaining 21 of 36 sequences are unique when compared to each other and are shown in the supporting information section, S3 Table.
α-chain TCR transcripts amplified by single Vα12-specific PCR vs.
1/20
vs.
2/20
aaa09npa08 C A L S E P F Q T G A N N L Vα12.1Jα36 p<0.0001 p<0.0001
tgtgctctgagt gagccttt tcaaactggggcaaacaacctc 11/20(55%)
aaa09va1201 C A L R G T N D Y K L Vα12.1Jα20 ns ns
tgtgctctg aggggga ctaacgactacaagctc 2/20(10%)
aaa09va1207 C A L S A G A S S S A S K I Vα12.1Jα3 ns ns
tgtgctctgagt gcaggcgcgtc cagcagtgcttccaagata 1/20(5%)
aaa09va1219 C A L S R G G N N R L Vα12.1Jα7 ns ns
tgtgctctgagt cgtgg tgggaacaacagactc 1/20(5%)
Remaining 5 of 20 sequences are unique when compared to each other and are shown in the supporting information section, S3 Table.
α-chain TCR transcripts amplified by single Vα6-specific PCR vs.
1/21
vs.
2/21
aaa09npa37 C A M R E I R T S Y D K V Vα6.1Jα50 p = 0.06 ns
tgtgcaatgaga gagattcgg acctcctacgacaaggtg 3/21(14%)
aaa09va0609 C A M R E G L Y G G A T N K L Vα6.1Jα32 ns ns
tgtgcaatgaga gagggcctc tatggaggtgctacaaacaagctc 2/21(10%)
aaa09va0602 C A M R G G F G N V L Vα6.1Jα35 ns ns
tgtgcaatgaga ggg ggctttgggaatgtgctg 2/21(10%)
aaa09va0612 C A M R E G P G Y S S A S K I Vα6.1Jα3 ns ns
tgtgcaatgaga gagggccct gggtacagcagtgcttccaagata 1/21(5%)
aaa09va0608 C A M S P N R G G Y N K L Vα6.1Jα4 ns ns
tgtgcaatg agccctaacagg ggtggctacaataagctg 1/21(5%)
aaa09va0607 C A M R V N Y R A R R A L Vα6.1Jα5 ns ns
tgtgcaatgaga gtaaactatcggg cgggcaggagagcactt 1/21(5%)
Remaining 11 of 21 sequences are unique when compared to each other and are shown in the supporting information section, S3 Table.
α-chain TCR transcripts amplified by single Vα9-specific PCR vs.
1/19
vs.
2/19
(Continued)
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Table 4. (Continued)
Clone Vα N Jα Transcript Frequency in
Specimen
p value
aaa09npa16 C A L S R G S Q G N L Vα9.1Jα42 p = 0.06 ns
tgtgctctg tcta gaggaagccaaggaaatctc 3/19(16%)
aaa09npa12 C A L R F R A Y S S A S K I Vα9.1Jα3 ns ns
tgtgctctg cgattccgtgcc tacagcagtgcttccaagata 2/19(11%)
aaa09va0906 C A L S G S G N T G K L Vα9.1Jα37 ns ns
tgtgctcta a gtggctctggcaacacaggcaaacta 2/19(11%)
aaa09npa24 C A L S R S G T R L Vα9.1Jα58 ns ns
tgtgctctaagt cggtccggga ctaggttg 2/19(11%)
aaa09va0902 C A L S G D N F N K F Vα9.1Jα21 ns ns
tgtgctctaagt gggg acaacttcaacaaattt 1/19(5%)
aaa09npa42 C A Q S P G Y N K L Vα9.1Jα4 ns ns
tgtgct cagtccc ctggtggctacaataagctg 1/19(5%)
aaa09va0905 S A S E G H G G S Q G N L Vα9.1Jα42 ns ns
tcagcc tcagaaggtc atggaggaagccaaggaaatctc 1/19(5%)
Remaining 7 of 19 sequences are unique when compared to each other and are shown in the supporting information section, S3 Table.
PATIENT AAA00
α-chain TCR transcripts following Vα2-specific PCR vs.
1/15
vs.
2/15
aaa00va0201 C V V T G T G G F K T Vα2.3Jα9 p<0.0001 p<0.0001
tgtgtggtg acggga actggaggcttcaaaact 15/15 (100%)
α-chain TCR transcripts following Vα8-specific PCR
vs.
1/15
vs.
2/15
aaa00va0801 C A E E G G S N Y K L Vα8.2Jα54 p<0.0001 p<0.0001
tgtgcagag gag ggaggtagcaactataaactg 15/15 (100%)
PATIENT AAA10
α-chain TCR transcripts amplified by NPA-PCR/Vα-specific PCR vs.
1/30
vs.
2/30
aaa10npa03 C A M T P P G G G T S Y G K L Vα6.1Jα53 p = 0.06 ns
tgtgcaatg acacctcccggg ggtggtactagctatggaaagctg 3/30(10%)
aaa10npa04 C A M R E T N T D K L Vα6.1Jα34 ns ns
tgtgcaatg agagaaacg aacaccgacaagctc 2/30(7%)
aaa10npa07 C A P F G G S N S G Y A L Vα13.1Jα41 ns ns
tgtgct cccttcggcggg tcaaattccgggtatgcactc 2/30(7%)
aaa10npa022 C G A D Y P S G T Y K Y Vα26.1Jα40 ns ns
tgtggagca gactatc cctcaggaacctacaaatac 2/30(7%)
aaa10npa09 C A T D Y S G S A R Q L Vα3.1Jα22 ns ns
tgtgctacg gactac tctggttctgcaaggcaactg 1/30(3%)
aaa10npa44 C A T P K S G T Y K Y Vα3.1Jα40 ns ns
tgtgctacc cctaag tcaggaacctacaaatac 1/30(3%)
aaa10npa43 C A T D A R H S N S G Y A L Vα3.1Jα41 ns ns
tgtgctacg gacgcccgcc actcaaattccgggtatgcactc 1/30(3%)
Remaining 18 of 30 sequences are unique when compared to each other and are shown in the supporting information section, S4 Table.
α-chain TCR transcripts following Vα6-specific PCR vs.
1/21
vs.
2/21
aaa10npa03 C A M T P P G G G T S Y G K L Vα6.1Jα53 p = 0.01 p = 0.09
tgtgcaatg acacctcccggg ggtggtactagctatggaaagctg 4/21(19%)
aaa10npa29 C A M R E A Y S G N Q F Y Vα6.1Jα49 p = 0.01 p = 0.09
(Continued)
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against the alternative hypothesis that only a single α-chain TCR is expressed twice, 2/n = 2/
57, and all remaining α-chain TCR transcripts sequenced were expressed only once, was
p = 0.034; (ii) Clone aaa03npa21 accounted for 5 of 57 identical transcripts (9%)(p = 0.003 vs.
1/57 and p = 0.034 vs. 2/57)(Vα24.1Jα47) (CDR3: AGR); (iii) clone aaa03npa09 accounted for
4 of 57 identical transcripts (7%)(p = 0.015 vs. 1/57 and p = 0.089 vs. 2/57)(Vα14.1Jα47)
(CDR3:IS); (iv) clone aaa03npa33 accounted for 4 of 57 identical transcripts (7%)(p = 0.015 vs.
1/57 and p = 0.089 vs. 2/57) (Vα6.1Jα54) (CDR3: EGE). (v) Clones aaa03npa16 and
aaa03npa02 accounted each for 3 of 57 identical transcripts (p = 0.06); six clones were
expressed in duplicate and the remaining 21 clones were unique when compared to each
other. Eighteen of 57 of those clones are shown in the supporting information section (S2
Table).
The Vα5.1Jα3 clonal expansion (clone aaa03npa04)(CDR3:LE), identified by NPA-PCR/
Vα-specific PCR, was confirmed by Vα5-specific PCR followed by cloning and sequencing
(Table 4). Twenty of 20 (100%) (p<0.0001) Vα5.1Jα3 transcripts were identical to the clonally-
expanded aaa03npa04 clone which was initially identified by NPA-PCR/Vα-specific PCR
Table 4. (Continued)
Clone Vα N Jα Transcript Frequency in
Specimen
p value
tgtgcaatgaga gaggcgtact ccggtaaccagttctat 4/21(19%)
aaa10va0601 C A M R E V D T G G F K T Vα6.1Jα9 ns ns
tgtgcaatgaga gaggtcg atactggaggcttcaaaact 2/21(10%)
aaa10va0610 C A M R E T N T D K L Vα6.1Jα34 ns ns
tgtgcaatgaga gaaacg aacaccgacaagctc 2/21(10%)
aaa10va0614 C A M R P R S G Y S T L Vα6.1Jα11 ns ns
tgtgcaatgaga ccgag gaattcaggatacagcaccctc 2/21(10%)
aaa10va0620 C A M S P M D S S Y K L Vα6.1Jα12 ns ns
tgtgcaatg agtcc gatggatagcagctataaattg 1/21(5%)
aaa10va0618 C A M R E A L M D S S Y K L Vα6.1Jα12 ns ns
tgtgcaatgaga gaggccctt atggatagcagctataaattg 1/21(5%)
aaa10va0602 C A M R D G Q K L Vα6.1Jα15 ns ns
tgtgcaatgaga ga tggccagaagctg 1/21(5%)
Remaining 4 of 21 sequences are unique when compared to each other and are shown in the supporting information section, S4 Table.
PATIENT AAA12
α-chain TCR transcripts amplified by NPA-PCR/Vα-specific PCR vs.
1/31
vs.
2/31
aaa12npa26 C A V S A K N N N A R L Vα13.1Jα31 ns ns
tgtgctgtg tctgcgaa gaataacaatgccagactc 2/31(6%)
aaa12npa02 C A P E G G G G A D G L Vα13.1Jα45 ns ns
tgtgcc ccggagggg ggaggaggtgctgacggactc 2/31(6%)
aaa12npa16 C G A H S N S G G G A D G L Vα26.1Jα45 ns ns
tgtggagcc cactcaa attcaggaggaggtgctgacggactc 2/31(6%)
aaa12npa07 C A L R N Q T G T A L Vα5.1Jα15 ns ns
tgtgctctc cgt aaccagacaggaactgctctg 1/31(3%)
aaa12npa04 C A L E G D N A G N M L Vα5.1Jα39 ns ns
tgtgctcta gaagggg ataatgcaggcaacatgctc 1/31(3%)
aaa12npa28 C A M T S K T I I F G Q Vα6.1Jα37 ns ns
tgtgcaatg acctctaaaacaa taatctttgggcaa 1/31(3%)
Remaining 22 of 31 sequences are unique when compared to each other and are shown in the supporting information section, S5 Table.
https://doi.org/10.1371/journal.pone.0218990.t004
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(Table 4). The Vα24.1Jα47 clonal expansion (clone aaa03npa21) (CDR3: AGR) was confirmed
by Vα24-specific PCR followed by cloning and sequencing. Thirteen of 22 (59%) (p<0.0001)
Vα24.1 transcripts were identical to the clonally expanded aaa03npa21 clone, initially identi-
fied by NPA-PCR/Vα-specific PCR (Table 4). Another Vα24 clonal expansion was identified
by Vα24-specific PCR followed by cloning and sequencing (clone aaa03Va2401) and
accounted for 6 of 22 (27%) (p = 0.0003) identical transcripts (Vα24.1Jα6). Clone
aaa03Va2408 (Vα24.1Jα9) was expressed in triplicate (Table 4).
Sequence analysis of α-chain TCR transcripts from AAA tissue from patient AAA09 after
NPA-PCR/Vα-specific PCR followed by cloning and sequencing revealed (Table 4) the pres-
ence of: (i) clone (aaa09npa08) that accounted for 3 of 36 identical transcripts (8%)
(Vα12.1Jα36)(CDR3: EPF) (p = 0.06); (ii) clone (aaa09npa16) that accounted for 3 of 36 iden-
tical transcripts (8%) (Vα9.1Jα42) (CDR3:SR) (p = 0.06). Three α-chain TCR clones were
expressed in duplicate. Remaining 24 of 36 α-chain TCR clones were unique when compared
to each other and are shown in Table 4 (3 clones)] and in the supporting information section
(S3 Table)(21clones).
The Vα12.1Jα36 clonal expansion identified by NPA-PCR/Vα-specific PCR, was confirmed
by Vα12-specific PCR followed by cloning and sequencing (Table 4). Eleven of 20 (55%)
(p<0.0001) Vα12.1Jα36 transcripts were identical to the clonally-expanded aaa03npa08 clone
identified by NPA-PCR/Vα-specific PCR (Table 4). One Vα12.1 clone was present in duplicate.
Remaining 7 T-cell clones were unique when compared to each other and are shown in Table 4
and in S3 Table. Clone (aaa09npa23) identified (single copy) by NPA-PCR/Vα.12.1-specific
PCR (S3 Table) was also found (single copy) after Vα12.1-specific PCR (S3 Table).
Clone aaa09npa37, Vα6.1Jα50 (CDR3: EIR) was expressed in triplicate and accounted for 3
of 21 identical transcripts (14%) (p = 0.06) as determined by Vα6-specific PCR amplification,
cloning and sequencing (Table 4). The same clone Vα6.1Jα50 was found to be expressed in
duplicate (2 of 36; 6%; p = 0.19) by NPA-PCR/Vα-specific PCR (Table 4). Remaining 14 Vα6.1
α-chain clones identified by Vα6-specific PCR, were unique when compared to each other and
are shown in Table 4 (three) and S3 Table (eleven). However, three clones aaa09npa15,
aaa09npa35 and aaa09npa45 were identified by both NPA-PCR/Vα-specific PCR and
Vα6-specific PCR followed by cloning and sequencing and were present in single copies
(Table 4 and S3 Table).
Several clones identified by NPA-PCR/Vα-specific PCR followed by cloning and sequenc-
ing were also identified by Vα9.1-specific PCR (Table 4). Clone aaa09npa16, Vα9.1Jα42
(CDR3:SR) accounted for 3 of 36 identical α-chain transcripts (8%) (p = 0.06) and was identi-
fied by NPA-PCR/Vα9.1-specific PCR. The same clone Vα9.1Jα42, CDR3:SR, was identified
by Vα9.1-specific PCR and accounted for 3 of 19 identical α-chain TCR transcripts (16%)
(p = 0.06). Clones aaa09npa16, aaa09npa24, aaa09npa42, and aaa09npa34 were identified by
both NPA-PCR/Vα-specific PCR and Vα9.1-specific PCR amplification, 3 out of 4 were pres-
ent in single copies, and one in duplicate (Table 4 and S3 Table). Seven of 19 clones were
unique when compared to each other and are shown in S3 Table.
Vα2-specific PCR amplification of TCR transcripts from AAA lesions from patient AAA00
followed by cloning and sequencing demonstrated 15 of 15 identical Vα2-chain TCR tran-
scripts (100%) (p<0.0001)(clone aaa00va0201)(Vα2.3Ja9)(Table 4). Vα8-specific PCR of TCR
transcripts from AAA lesions from patient AAA00, followed by cloning and sequencing,
revealed 15 of 15 identical Vα8-chain TCR transcripts (100%)(p<0.0001)(clone aaa00va0801)
(Vα8.2Jα54) (Table 4).
Sequence analysis of α-chain TCR transcripts from AAA lesions from patient AAA10 after
NPA-PCR/Vα-specific PCR amplification and cloning, showed 3 of 30 (10%) identical α-
chain TCR transcripts (clone aaa10npa03)(p = 0.06)(Vα6.1Jα53)(CDR3:TPPG)(Table 4).
Clonally expanded alpha-chain T-cell receptor (TCR) transcripts in Abdominal Aortic Aneurysm (AAA)
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Clones, aaa10npa04 (Vα6.1Jα34), aaa10npa07 (Vα13.1Jα41), and aaa10npa22 (Vα26.1Jα40)
were expressed in duplicate. Remaining α-chain transcripts were unique when compared to
each other and are shown in Table 4 (three clones) and S4 Table (15 clones).
The Vα6.1Jα53 clonal expansion, identified by NPA-PCR/Vα-specific PCR amplification
was confirmed by Vα6-specific PCR followed by cloning and sequencing (Table 4). Four of 21
identical TCR transcripts (19%)(p = 0.01)(clone aaa10npa03)(Vα6.1Jα53)(CDR3:TPPG) iden-
tified by Vα6-specific PCR, cloning and sequencing, were identical to clone aaa10npa03,
Vα6.1Jα53, CDR3:TPPG, identified by NPA-PCR/Vα-specific PCR (3 of 30 identical tran-
scripts) (Table 4 and S4 Table).
Vα6-specific PCR amplification, cloning and sequencing showed an additional clonal
expansion of 4 of 21 identical TCR transcripts (19%)(p = 0.01)(clone aaa10npa29)(Vα6.1Jα49)
(CDR3:EAYS)(Table 4). This aaa10npa29 clone was also identified after NPA-PCR/Vα-spe-
cific PCR (single transcript, 1 of 30). Three clones amplified by Vα6-specific PCR were
expressed in duplicate and 7 clones were expressed in single copies (Table 4 and S4 Table).
Sequence analysis of α-chain TCR transcripts after NPA-PCR/Vα-specific PCR amplifica-
tion and cloning from AAA lesions from patient AAA12, revealed 3 clones aaa12npa26
(Vα13.1Jα31), aaa12npa02 (Vα13.1Jα45) and aaa12npa16 (Vα26.1Jα45) expressed in duplicate
(2 of 31; 6%; p = 0.19)(Table 4). Remaining 25 α-chain TCR transcripts were unique when
compared to each other and are shown in Table 4 (three clones) and S5 Table (nineteen
clones). Further analysis of TCR transcripts from patient AAA12 was not carried out.
Grossly normal autopsy specimens of infrarenal abdominal aortas from 3 patients who died
of nonvascular diseases were used as controls. RNA was prepared and β-chain TCR NPA-PCR
/Vβ-specific PCR revealed the absence of β-chain TCR transcripts and of infiltrating T cells in
these non-aneurysmal aortic tissue specimens [41]. These findings are in agreement with the
reports of others that T cells or CD45+ cells are absent in nonaneurysmal aortic tissue
[7,72,73]. Along these lines, we have reported the absence of infiltrating T cells from central
epicardial arteries [61].
PBMC from normal donors (methodological controls) are comprised of
polyclonal T cells
We employed PBMC from 3 normal donors as methodological controls to ensure that all meth-
ods used in this study were performing well, as expected. Sequence analysis of α-chain TCR
transcripts after NPA-PCR/Vα-specific PCR and cloning demonstrated that these transcripts
were productively rearranged human α-chain TCR transcripts and typical of polyclonal T cells
(Table 5, normal donor 1) (S6 Table), in agreement with our previous findings [59,60]. A total
of 170 α-chain TCR transcripts were sequenced from PBMC from normal donors (Table 5, S6
Table, and [59,60]) and all were unique when compared to each other with the exception of 12
of 170 transcripts (7%), which appeared in duplicate: (i) 2 of 28, normal donor 1 (Table 5); (ii) 2
of 47, normal donor 2 (S6 Table); (iii) 6 of 50, normal donor 3 (S6 Table); (iv) 1 of 25 [59]; and
(v) 1 of 20 [60]. As it was mentioned in Methods (above), appearance in two different colonies
of an identical α-chain TCR transcript, designated as a doublet, may indicate the beginning of a
clonal expansion or may be the result of an artifact of the E. coli transfection method, and in
particular of a single E. coli cell that was transformed and divided (doubled) before plating.
Control studies using PBMC from normal donors demonstrate that these
results reveal true clonal expansions of T cells
The clonal expansions reported here were obtained by amplifying TCR transcripts by two PCR
methods. An argument could be made that in the event that these two PCR amplifications
Clonally expanded alpha-chain T-cell receptor (TCR) transcripts in Abdominal Aortic Aneurysm (AAA)
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Table 5. α-chain TCR Transcripts (CDR3 Region) Identified in PBMC from Normal Donors.
Clone Vα N Jα Transcript Frequency in Specimen p value
α-chain TCR transcripts from Normal Donor 1 amplified by NPA-PCR/Vα-specific PCR vs.
1/28
vs.
2/28
NBAnpa09 C A M R E G R V G T A S K L Vα6.1Jα44 ns ns
tgtgcaatgaga gagggccgtgt cggcactgccagtaaactc 2/28
NBAnpa12 C A L R G L I K A A G N K L Vα12.1Jα17 ns ns
tgtgctctg agggggt tgatcaaagctgcaggcaacaagcta 1/28
NBAnpa28 C A V N R G Y Q K V Vα2.1Jα13 ns ns
tgtgccgtg aata ggggttaccagaaagtt 1/28
NBAnpa02 C A T E G V D Y K L Vα3.1Jα20 ns ns
tgtgctacg gagggggt cgactacaagctc 1/28
NBAnpa16 C A M R A G P G T A L Vα6.1Jα15 ns ns
tgtgcaatgaga gccggtc caggaactgctctg 1/28
NBAnpa07 C A M R E G G D N Y G Q N F Vα6.1Jα26 ns ns
tgtgcaatgaga gagggcg gggataactatggtcagaatttt 1/28
NBAnpa36 C A L K A G G S Y I P Vα9.1Jα6 ns ns
tgtgctcta aagg caggaggaagctacatacct 1/28
NBAnpa05 C A G A V P K Y G N K L Vα10.1Jα47 ns ns
tgtgcagga gctgtcccca aatatggaaacaaactg 1/28
NBAnpa03 C A L S F N A G N N R K L Vα12.1Jα38 ns ns
tgtgctctgagt tt taatgctggcaacaaccgtaagctg 1/28
NBAnpa34 C A V T T T G A N S K L Vα13.1Jα56 ns ns
tgtgctgtg acaacg actggagccaatagtaagctg 1/28
NBAnpa23 C A V T R T G A N I K L Vα13.1Jα56 ns ns
tgtgctgtg acacga actggagccaatattaagctg 1/28
NBAnpa08 C A E S I S S S A S K I Vα15.1Jα3 ns ns
tgtgcagagagt ataag cagcagtgcttccaagata 1/28
NBAnpa27 C A E S S L N T G G F K T Vα15.1Jα9 ns ns
tgtgcagagagt tccctt aatactggaggcttcaaaact 1/28
NBAnpa22 C A E L N Q A G T A L Vα15.1Jα15 ns ns
tgtgcagag ctaa accaggcaggaactgctctg 1/28
NBAnpa21 C A E S M T A A G N K L Vα15.1Jα17 ns ns
tgtgcagagagt atgacg gctgcaggcaacaagcta 1/28
NBAnpa32 C A A S R M D S N Y Q L Vα17.1Jα33 ns ns
tgtgcagcaagc agaa tggatagcaactatcagtta 1/28
NBAnpa37 C A V R Y L G G G A T N K L Vα19.1Jα32 ns ns
tgtgctgtc agatatttagggggt ggtgctacaaacaagctc 1/28
NBAnpa29 C A V V M Y G N K L Vα19.1Jα47 ns ns
tgtgctgtc gtgatg tatggaaacaagctg 1/28
NBAnpa25 C L V G P F N N A R L Vα20.1Jα31 ns ns
tgcctcgtg ggtccctt taacaatgccagactc 1/28
NBAnpa15 C A G Q L D N T D K L Vα25.1Jα34 ns ns
tgtgctggg cagctgg ataacaccgacaagctc 1/28
NBAnpa20 C A G L S G T Y K Y Vα25.1Jα40 ns ns
tgtgctggt ct ctcaggaacctacaaatac 1/28
NBAnpa35 C A G P R T G T A S K L Vα25.1Jα44 ns ns
tgtgctggg ccgagg accggcactgccagtaaactc 1/28
NBAnpa33 C G A D R G D S S Y K L Vα26.1Jα12 ns ns
(Continued)
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were performed only from very few T cells, then it could be possible that each pair of amplifi-
cation primers would amplify TCR transcripts from only few T cells, yielding findings that
could resemble those shown in this paper. We have carried out extensive control experiments
[41,58,59,62,63] using β-chain TCR transcripts demonstrating that this is not the case, that
these results are true clonal expansions of T cells and they are not due to PCR amplification of
TCR transcripts from just a few numbers of T cells. These results have been presented else-
where [41,58,59,62,63] and will be briefly discussed here to address this point.
As it was mentioned above, each specimen containing AAA lesions from patients with
AAA was divided into two halves. One half was employed for immunohistochemistry and the
other half for RNA preparation, and TCR amplification, cloning and sequencing. The yield of
RNA was approximately 10 μg per preparation, which represents approximately 1.0 x 107 cells.
An amount of 50 ng of RNA was used for each PCR amplification, cloning and sequencing. It
is estimated that these 50 ng of RNA are isolated from approximately 5.0 x 104 cells.
The representation (ratio) of different TCR clones is the same in a sample of 10 μg RNA
and a sample of 50 ng RNA that we employed for PCR, cloning, and sequencing. The clonally
expanded TCR transcripts that were identified in 10 μg RNA, are also present in 50 ng RNA;
the ratio of the different clonally expanded TCR transcripts to each other does not change.
However, when different amounts of RNA are used in the PCR amplification the absolute
number of copies of the clonally expanded TCR transcripts that are present is different.
We employed an anti-CD3 mab and immunohistochemical staining to determine the num-
bers of CD3+ T lymphocytes present in AAA specimens that we used for RNA preparation
from patients AAA09 and AAA10. CD3+ T cells were counted in a large number (twenty) of
high power fields per specimen by two different observers, independently. CD3+ T cell num-
bers varied substantially (range 0 to 155 CD3+ T lymphocytes) among each high power field.
An average number of CD3+ T lymphocytes of approximately 780 per section and 660 per sec-
tion were found in specimens AAA09 and AAA10, respectively. Because the thickness of aorta
tissue specimens was approximately 5 mm and the thickness of the cryostat sections of the
aorta specimens used were 6 μm thick, the total number of CD3+ T lymphocytes employed for
RNA isolation from aortic specimens from patients AAA09 and AAA10 were estimated to be
6.5x105 and 5.5x105, respectively. In consideration that 10 μg of RNA, derived from approxi-
mately 1x107 total cells present in these specimens, was recovered per preparation, CD3+ T
lymphocytes alone in the AAA09 and AAA10 specimens were 6.5% and 5.5%, respectively
(mean 6%), of the total cells employed to isolate RNA. An amount of 50 ng of RNA, represent-
ing approximately 5x104 cells, were employed for PCR amplification. CD3+ T lymphocytes
accounted for about 6% of these cells, i.e., approximately 3,000 T cells.
Table 5. (Continued)
Clone Vα N Jα Transcript Frequency in Specimen p value
tgtggagcagac cgagg ggatagcagctataaattg 1/28
NBAnpa30 C G P L V P H S G G G A D G L Vα26.1Jα45 ns ns
tgtgga cccctcgtacctc attcaggaggaggtgctgacggactc 1/28
NBAnpa10 C R N L L L H M D T G R R A L Vα30.1Jα5 ns ns
tgtaggaaccta ctcctccaca tggacacgggcaggagagcactt 1/28
NBAnpa11 C L L G S T F Y N N N D M Vα31.1Jα43 ns ns
tgtcttctggga tctaccttct acaataacaatgacatg 1/28
Results from normal donors 2 and 3 are shown in the supporting information section S6 Table.
https://doi.org/10.1371/journal.pone.0218990.t005
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Further control experiments were performed to identify the threshold of the minimum
number of CD3+ T lymphocytes present in normal donor PBMCs that will provide polyclonal
TCR transcripts after two PCR cycles, cloning and sequencing. Sequence analysis, after
NPA-PCR amplification with various amounts of cDNA template and cloning, starting with as
low as 300 T cells [41], demonstrated the presence of unique transcripts when compared with
each other, except of two TCR transcripts which were present in duplicate (statistically not sig-
nificant), typical of polyclonal T cells. The numbers of these T lymphocytes were 10 times
lower than those present in AAA specimens used in these experiments (i.e., 3,000 T lympho-
cytes, as determined by immunohistochemistry using an anti-CD3 mab, see above).
The same approach was used in connection with Vβ-specific PCR, followed by cloning and
sequencing [41,58,59,62,63]. Vβ2-specific PCR followed by cloning and sequencing of normal
donor PBMC containing as low as 1,200 T cells and an estimated 100 Vβ2+ T lymphocytes (in
50 ng RNA), demonstrated unique Vβ2+ TCR transcripts when compared to each other with
the exception of two TCR transcripts present in duplicate (not statistically significant), typical
of polyclonal T lymphocyte populations. The T cell numbers, 1,200 T cells, used in these exper-
iments were lower than those, 3,000 T cells, in 50 ng RNA from AAA specimens.
Sequence analysis after Vβ2-specific PCR amplification and cloning, from another mixture
that contained only 300 T cells from the peripheral blood of normal donors, corresponding to
24 Vβ2+ T lymphocytes, showed a more restricted pattern, consisting of the following [41]: (i)
one Vβ2+ transcript in triplet; (ii) 4 transcripts in duplicate copies; and (iii) 8 other transcripts
in a single copy. These clonal expansions are not statistically significant. These findings con-
firm that the clonal expansions of T lymphocytes identified in AAA lesions represent real
clonal expansions and are not due to amplifications of TCR transcripts from just a few T cells.
DNA-based HLA-typing for HLA-DRB1, -DQA1 and -DQB1
Three of 5 patients with AAA were typed by DNA-based HLA-typing for HLA-DRB1, -DQA1
and -DQB1 (Table 6). All three patients, AAA03, AAA09 and AAA10, expressed DRB1 alleles
positive for the DRβGln70 amino acid residue, which was reported to be associated with AAA
[21]. Clonally expanded T cells in AAA lesions were present in all these 3 patients (Table 4).
DNA-based HLA-typing of six patients with AAA, including the three patients shown here,
has been reported previously [41], and is shown here to present a complete picture.
Conserved CDR3 amino acid motifs
A substantial number of CDR3 amino acid motifs were found in higher proportions in the
TCR CDR3 from AAA lesions of patients with AAA vs. those of PBMC from normal donors,
which were used as methodological controls (Table 7). These CDR3 amino acid motifs were
selected with two amino acids each, because examination of the CDR3 sequences identified in
Table 6. DNA-based typing for HLA-DRB1, -DQA1 and -DQB1 loci of patients with AAA�.
Sample Name DRB1-1 DRB1-2 DQA1-1 DQA1-2 DQB1-2 DQB1-2 DRβQ70
AAA03 0301 0101 0101 0501 0201 0501 +
AAA09 0101 0701 0101 0201 0202 0501 +
AAA10 0301 1501 0102 0501 0201 0602 +
� DNA-based HLA-typing results of these three patients with AAA have been reported previously [41] as part of a larger series and are shown here for the shake of
completion. Reproduced in part, with the permission of The American Association of Immunologists, Inc., from Lu et al, J. Immunol., 192: 4897–4912, 2014 (reference
[41]). Copyright 2014. The American Association of Immunologists, Inc.
https://doi.org/10.1371/journal.pone.0218990.t006
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AAA lesions revealed the presence of CDR3 motifs comprised of two amino acids each that
were expressed in high proportions in more than one patients with AAA. The proportions of
these CDR3 two amino acid motifs in patients with AAA were compared to the proportions of
these CDR3 two amino acid motifs in PBMC from normal donors (Table 7) and were statisti-
cally significant by the differences in Poisson rates. The percent proportions of 17 of 28 CDR3
Table 7. CDR3 α-chain TCR conserved amino acid motifs found in AAA lesions of patients with AAA.
CDR3 Motif AAA Patient
AAA03 AAA09 AAA00 AAA10 AAA12 Normal PBMC
AG 26/99 (26%) 8/96 (8%) 0/30 (0%) 1/51 (2%) 2/31 (6%) 40/170 (23%)
AL 28/99 (28%) 48/96 (50%) 0/30 (0%) 2/51 (4%) 3/31 (10%) 25/170 (15%)
AY 6/99 (6%) 2/96 (2%) 0/30 (0%) 7/51 (14%) 0/31 (0%) 4/170 (2%)
EA 1/99 (1%) 2/96 (2%) 0/30 (0%) 6/51 (12%) 0/31 (0%) 2/170 (1%)
EE 4/99 (4%) 0/96 (0%) 15/30 (50%) 0/51 (0%) 6/31 (19%) 1/170 (0.5%)
EG 36/99 (36%) 11/96 (11%) 15/30 (50%) 2/51 (4%) 5/31 (16%) 9/170 (5%)
EP 0/99 (0%) 14/96 (15%) 0/30 (0%) 0/51 (0%) 0/31 (0%) 1/170 (0.5%)
GG 21/99 (21%) 23/96 (24%) 30/30 (100%) 30/51 (59%) 22/31 (71%) 42/170 (25%)
GGG 4/99 (4%) 2/96 (2%) 0/30 (0%) 8/51 (16%) 0/31 (0%) 8/170 (5%)
GR 18/99 (18%) 2/96 (2%) 0/30 (0%) 1/51 (2%) 0/31 (0%) 8/170 (5%)
GS 20/99(20%) 17/96 (18%) 15/30 (50%) 5/51 (10%) 3/31 (10%) 35/170 (20%)
GT 5/99 (5%) 6/96 (6%) 15/30 (50%) 14/51 (27%) 2/31 (6%) 16/170 (9%)
LE 25/99 (25%) 0/96 (0%) 0/30 (0%) 0/51 (0%) 0/31 (0%) 9/170 (5%)
PF 0/99 (0%) 14/96 (15%) 0/30 (0%) 3/51 (6%) 0/31 (0%) 52/170 (30%)
PP 0/99 (0%) 0/96 (0%) 0/30 (0%) 7/51 (14%) 2/31 (6%) 0/170 (0%)
RE 23/99 (23%) 16/96 (17%) 0/30 (0%) 14/51 (27%) 1/31 (3%) 3/170 (2%)
RG 0/99 (0%) 18/96 (19%) 0/30 (0%) 0/51 (0%) 3/31 (10%) 2/170 (1%)
SA 39/99 (39%) 10/96 (10%) 0/30 (0%) 0/51 (0%) 3/31 (10%) 6/170 (3%)
SE 0/99 (0%) 20/96 (21%) 0/30 (0%) 0/51 (0%) 0/31 (0%) 14/170 (8%)
SG 17/99 (17%) 19/96 (20%) 0/30 (0%) 18/51 (35%) 4/31 (13%) 32/170 (19%)
SS 35/99 (35%) 8/96 (8%) 0/30 (0%) 3/51 (6%) 5/31 (16%) 7/170 (4%)
SY 10/99 (10%) 4/96 (4%) 0/30 (0%) 10/51 (20%) 3/31 (10%) 29/170 (17%)
TG 7/99 (7%) 24/96 (25%) 30/30 (100%)� 6/51 (12%) 0/31 (0%) 9/170 (5%)
TP 1/99 (1%) 1/96 (1%) 0/30 (0%) 8/51 (16%) 0/31 (0%) 20/170 (12%)
VS 24/99 (24%) 1/96 (1%) 0/30 (0%) 0/51 (0%) 5/31 (16%) 27/170 (16%)
VT 2/99 (2%) 1/96 (1%) 15/30 (50%) 1/51 (2%) 1/31 (3%) 2/170 (1%)
VV 28/99 (28%) 1/96 (1%) 15/30 (50%) 0/51 (0%) 5/31 (16%) 13/170 (8%)
YS 26/99 (26%) 6/96 (6%) 0/30 (0%) 8/51 (16%) 0/31 (0%) 5/170 (3%)
�Each one of 15 transcripts expressed 2 TG amino acid motifs (30 transcripts were sequenced from patient AAA00).
Statistical Analysis: AG: AAA vs. Normal PBMC, p = 0.0034; AL: AAA vs. Normal PBMC, p = 0.0106; AY: AAA vs. Normal PBMC, p = 0.1941; EA: AAA vs. Normal
PBMC, p = 0.2398; EE: AAA vs. Normal PBMC, p = 0.0100238; EG: AAA vs. Normal PBMC, p<0.0001; EP: AAA vs. Normal PBMC, p = 0.0479; GG: AAA vs. Normal
PBMC, p = 0.0044; GGG: AAA vs. Normal PBMC, p = 0.9435; GR: AAA vs. Normal PBMC, p = 0.3680; GS: AAA vs. Normal PBMC, p = 0.8067; GT: AAA vs. Normal
PBMC, p = 0.2030; LE: AAA vs. Normal PBMC, p = 0.2680; PF: AAA vs. Normal PBMC, p<0.0001; PP: AAA vs. Normal PBMC, p = 0.1276; RE: AAA vs. Normal
PBMC, p = 0.0001; RG: AAA vs. Normal PBMC, p = 0.0174; SA: AAA vs. Normal PBMC, p = 0.0002; SE: AAA vs. Normal PBMC, p = 0.5012; SG: AAA vs. Normal
PBMC, p = 0.9867; SS: AAA vs. Normal PBMC, p = 0.0005; SY: AAA vs. Normal PBMC, p = 0.0132; TG: AAA vs. Normal PBMC, p<0.0001; TP: AAA vs. Normal
PBMC, p = 0.0009; VS: AAA vs. Normal PBMC, p = 0.0671; VT: AAA vs. Normal PBMC, p = 0.0210; VV: AAA vs. Normal PBMC, p = 0.0183; YS: AAA vs. Normal
PBMC, p = 0.0017.
https://doi.org/10.1371/journal.pone.0218990.t007
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two amino acid motifs identified in AAA lesions were statistically significant in comparison to
the percent proportions of these CDR3 two amino acid motifs expressed in PBMC from nor-
mal donors. We have previously used this approach to analyze CDR3 motifs [41]. Certain α-
chain TCR CDR3 two amino acid motifs were found in increased proportions in more than
one AAA patient (Table 7). Different α-chain TCR CDR3 amino acid motifs were utilized by
different patients with AAA, suggesting the recognition of different peptide/MHC complexes
by clonally expanded T cells or other T-cell clones present in AAA lesions from different
patients. A total of 170 α-chain TCR transcripts from PBMC of 5 normal donors (Table 5 and
[59,60]), were used as normal controls (Table 7).
Comparison of the nucleic acid and deduced amino acid sequences of α-
chain TCR transcripts to those in the GENBANK/EMBL database
Comparison of all α-chain TCR sequences identified here to those in the GenBank/EMBL
database by the BLAST software showed that the α-chain TCR transcripts identified in this
study were novel and typical of α-chain TCR. None of the α-chain TCR transcripts reported
here were reported previously. Identical a-chain TCR transcripts were not found in AAA
lesions from different AAA patients. However, comparison of the CDR3 motifs of the clonally
expanded α-chain TCR transcripts in AAA lesions by the gapped BLAST and PSI BLAST pro-
tein database programs revealed certain highly homologous CDR3s between α-chain TCR
transcripts that were clonally expanded in AAA lesions to those previously reported in the
GenBank/EMBL. Currently, it has not been established what is the maximum number of
CDR3 amino acid differences that defines high or extensive CDR3 homology. We have chosen
arbitrarily that differences of two conservative and one non-conservative amino acids would
be the maximum number of differences allowed between CDR3 regions from different T-cell
clones in order to define high or extensive CDR3 homology. Most important homologies
include:
Patient AAA03 (Table 4): Clonally expanded clone aaa03npa04, CDR3: CALEGYSSASKI,
exhibited extensive CDR3 homology with 3 T-cell clones: (i) CDR3: CALASYSSASKI, Gen-
Bank Accession No. ANO54287.1; (ii) CDR3: CALSYSSASKI, GenBank Accession No.
ANO55176.1; (iii) CDR3: CAEKRGYSSASKI, GenBank Accession No. ANO54594.1; all iden-
tified in peripheral blood T cells of patients with Sjo¨gren’s syndrome (SS) [74]. Clone
aaa03npa04 showed extensive CDR3 homology with a T-cell clone, CDR3: CAAPGYSNASKI,
GenBank Accession No. AAA80058.1, found on anti-DNA antibody-helper T cells from the
peripheral blood of a lupus patient [75]. Clone aaa03npa33, CDR3: CAMREGEGGSNYKL,
showed high CDR3 homology with a T-cell clone, CDR3: CAVKEAGG GSNYKL, GenBank
Accession No. ANO55390.1 found in peripheral blood T cells of an SS patient [74].
Clonally expanded clone aaa03npa02, CDR3: CAGQKGGTSYGKL, exhibited extensive
CDR3 homology with 5 T-cell clones: (i) CDR3: CAAQGGTSYGKL, GenBank Accession No.
ANO54008.1; (ii) CDR3: CAANAGGTSYGKL, GenBank Accession No. ANO55694.1; both
identified in SG of patients with SS [74]; (iii) CDR3: CAGRNAGGTSYGKL, GenBank Acces-
sion No. ANO54097.1; (iv) CDR3: CAENGGTSYGKL, GenBank Accession No. ANO54594.1;
(v) CDR3: CAGAPAGGTSYGKL, GenBank Accession No. ANO54605.1; all 3 identified in
peripheral blood of patients with SS [74].
Clone aaa03npa16, CDR3: CAVEETSGSRL, had extensive CDR3 homology with 5 T-cell
clones: (i) CDR3: CAVVEETSGSRL, GenBank Accession No. ANO54242.1; (ii) CDR3: CAV-
RETSGSRL, GenBank Accession No. ANO56281.1; (iii) CDR3: CAVDRETSGSRL, GenBank
Accession No. ANO56267.1; all 3 found in salivary glands (SG) of SS patients [74]; (iv) CDR3:
CAVKETSGSRL, GenBank Accession No. BAF94397.1, human T-cell clone [76]; (v) CDR3:
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CAVRE TSGSRL, GenBank Accession No. AAB 97020.1; a human T-cell clone [77]. Clone
aaa03va2408, CDR3: CVAATGGFKT, had extensive CDR3 homology with 3 T-cell clones: (i)
CDR3: CAASTGGFKT, GenBank Accession No. ANO55378.1; (ii) CDR3: VADTGGFKT,
GenBank Accession No. ANO 54837.1; both identified in SGs of SS patients [74]; (iii) CDR3:
CAASTGGFKT, GenBank Accession No. AAC72697.1, human T-cell clone from the synovial
fluid of a patient with rheumatoid arthritis [78].
Patient AAA09 (Table 4): Clonally expanded clone aaa10npa08, CDR3: CALSEPFQTGAN
NL, had extensive CDR3 homology with a T-cell clone, CDR3: EYAQTGANNL, GenBank
Accession No. ANO56562.1, found in SG of an SS patient [74]. Clone aaa09npa16, CDR3:
CALSRGSQGNL, showed extensive CDR3 homology with 5 T-cell clones: (i) CDR3:
CALVRGSQGNL, GenBank Accession No. ANO56100.1; (ii) CDR3: CAMRDSRGSQGNL,
GenBank Accession No. ANO55703.1; (iii) CDR3: CAVRRGSQGNL, GenBank Accession No.
ANO55251.1; all 3 found in SGs of SS patients [74]; (iv) CDR3: CALGRNYGGSQGNL, Gen-
Bank Accession No. ANO54721.1; identified in peripheral blood T cells of an SS patient [74];
(v) CDR3: CAVIGRGSQGNL, GenBank Accession No. AAA80100.1; found on an anti-DNA
antibody helper T-cell clone from peripheral blood of a lupus patient [75]; (vi) CDR3:
CALSVGSQGNL, GenBank Accession No. AIE10490.1; found in a human T-cell clone [79].
Clone aaa 09npa37, CDR3: CAMREIRTSYDKV, had extensive CDR3 homology with a T-cell
clone, CDR3: CAM REYPSYDKV, GenBank Accession No. ABO16436.1; found in a patient
with renal cell carcinoma [80].
Patient AAA00 (Table 4): Clonally expanded clone aaa00va0201, CDR3: CVVTGTGGF
KT, had extensive CDR3 homology with 3 T-cell clones: (i) CDR3: CVVNGAGGFKT, Gen-
Bank Accession No. ANO55862.1; (ii) CDR3: CVVSDGTGGFKT, GenBank Accession No.
ANO56340.1; both identified in SGs of SS patients [74]; (iii) CDR3: CVVSEGTGGFKT, Gen-
Bank Accession No. ANO54058.1; found in peripheral blood T cells of an SS patient [74].
Clonally expanded clone aaa00va0801, CDR3: CAEEGGSNYKL, exhibited extensive CDR3
homology with: (i) CDR3: CAENRSGGSNYKL, GenBank Accession No. ANO55004.1; (ii)
CDR3: CAENSSGGSNYKL GenBank Accession No. ANO55130.1; both identified in periph-
eral blood of an SS patient [74].
Patient AAA10 (Table 4): Clonally expanded clone aaa10npa03, CDR3:CAMTPPGGGT-
SYGK had extensive CDR3 homology with a T-cell clone, CDR3: CAVSGPPAGGTSYGKL,
GenBank Accession No. ANO54194; found in peripheral blood T cells of an SS patient [74].
Clone aaa10npa29, CDR3: CAMREAYSGNQFY, had extensive CDR3 homology with a T-cell
clone, CDR3: CALSEANT GNQFY, GenBank Accession No. ANO55358; found in peripheral
blood T cells of an SS patient [74].
A substantial number of clonally expanded α-chain TCR clones found in AAA lesions from
patients with AAA, exhibited extensive CDR3 homology to T-cell clones found in SS patients.
Clonally expanded α- and β-chain TCR transcripts in AAA lesions of patients with
AAA. Four of 5 patients who demonstrated in this study statistical significant clonal
Table 8. TCR Clonal Expansions and Oligoclonality of T Cells Infiltrating AAA Lesions.
Patients with AAA Clonal Expansion/Oligoclonality
α-chain β-chain
AAA03 Yes Yes
AAA09 Yes Yes
AAA00 Yes Yes
AAA10 Yes Yes
AAA12 Polyclonal Polyclonal
https://doi.org/10.1371/journal.pone.0218990.t008
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expansions of α-chain TCR transcripts in AAA lesions, also exhibited statistically significant
clonal expansions of β-chain TCR transcripts. These results have been published previously
[41] and are summarized here (Tables 8 and 9) for comparison purposes. In contrast, patient
AAA12 exhibited polyclonal α- (Tables 4, 8 and 9) and β-chain [41] TCR transcripts in AAA
lesions.
Discussion
To determine whether clonally-expanded α-chain TCR transcripts are present in T cells infil-
trating AAA lesions from patients with AAA, we amplified α-chain TCR transcripts from
these lesions by NPA-PCR/Vα-specific PCR and cloned and sequenced the amplified tran-
scripts. Analysis of the sequences demonstrated the presence of high proportions of identical
α-chain TCR transcripts in 4 of 5 patients with AAA. These results were confirmed by two-
sided Vα-specific PCR, a independent amplification method, cloning and sequencing. Identi-
cal α-chain TCR clonal expansions to those obtained after NPA-PCR/Vα-specific PCR were
found. These results provide an important confirmation of the presence of oligoclonal T cells
in AAA lesions and strongly support the view that AAA is a specific antigen-driven T-cell
disease.
Previously, we reported that that β-chain TCR transcripts are clonally expanded in AAA
lesions from 8 of 10 patients with AAA [41]. In this study, we demonstrate that α-chain TCR
transcripts in AAA lesions are also clonally expanded. Four of 5 patients with AAA who exhib-
ited statistically significant α-chain TCR clonal expansions in AAA lesions, also exhibited sta-
tistically significant β-chain TCR clonal expansions [41] (Tables 8 & 9). AAA lesions from
patient AAA12 contained polyclonal α- and β-chain TCR transcripts (Tables 8 & 9). In the
studies reported here we have continued the testing of the hypothesis that T cells infiltrating
AAA lesions are oligoclonal and AAA is a specific antigen(s)-driven T-cell disease. To com-
plete the testing of this hypothesis additional studies will be needed to identify the antigen(s),
self or non-self, recognized by the clonally expanded α- and β-chain TCR.
Identical α-chain TCR transcripts were not identified in AAA lesions from different
patients with AAA. This is in agreement with our results [41,57–63,80,81] and those of others
[74–78,82] in a large number of studies demonstrating the absence of sharing among different
patients with the same disease of clonally expanded identical α- and β-chain TCR transcripts.
Similarly, entire CDR3 segments were not shared among different patients [41,57–63,74–
Table 9. Major Clonal Expansions of α- and β-chain TCR transcripts in AAA lesions.
Patient α-chain % identical transcripts β-chain % identical transcripts [41]
AAA09 Vα12.Jα36 11/20 55% p<0.0001� Vβ14.1Dβ2.1Jβ2.3 12/21 57% p<0.0001��
AAA00 Vα2.3Jα9
Vα8.2Jα54
15/15
15/15
100%
100%
p<0.0001�
p<0.0001�
Vβ5.1Dβ2.1Jβ2.3 6/34 17.6% p = 0.0004+
AAA03 Vα5.1Jα3
Vα24.1Jα47
20/20
13/22
100%
59%
p<0.0001�
p<0.0001�
Vβ24.1Dβ2.1β1.3
Vβ6.3Dβ2.1Jβ2.1
Vβ3.1Dβ2.1Jβ2.1
17/20
4/21 5/24
85%
19% 21%
p<0.0001��
p = 0.01��p = 0.002��
AAA10 Vα6.1Jα53
Vα6.1Jα49
4/21
4/21
19%
19%
p = 0.01�
p = 0.01�
Vβ3.1Dβ2.1Jβ2.1
Vβ3.1Dβ1.1Jβ1.5
10/41 6/41 24% 15% p<0.0001��
p = 0.0004��
AAA12 Not significant Not significant++
� Clonally expanded α-chain TCR transcripts following Vα-specific PCR amplification, cloning and sequencing (this report).
��Clonally expanded β-chain TCR transcripts following Vβ-specific PCR amplification, cloning and sequencing [41].
+Clonally expanded β-chain TCR transcripts following NPA-PCR/Vβ-specific PCR amplification, cloning and sequencing [41].
++ Following NPA-PCR/Vβ-specific PCR amplification, cloning and sequencing [41].
https://doi.org/10.1371/journal.pone.0218990.t009
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78,80,81]. There is extensive promiscuity in the interactions of TCR with peptide/MHC and a
number of reasons may be responsible (reviewed in [80]): (i) Different T-cell clones expressing
different TCR recognize peptides bound to different MHC class I or II alleles. Different pep-
tides from the same antigens may be presented to T cells; (ii) Different antigenic peptides bind
to the same MHC allele and these different peptide:MHC complexes may be recognized by dif-
ferent TCR; (iii) Different epitopes of a single peptide:MHC complex may be recognized by
different TCR; (iv) The same peptide:MHC epitope may be recognized by several different
TCR; (v) Several amino acids of the CDR3 are TCR clone specific and may be coded, at least in
part, by random additions of N-nucleotide (nontemplated nucleotides) during the generation
of T-cell diversity and not by nucleotides belonging to V, D (β-chain only) or J gene segments
[74]. However, a substantial number of CDR3 amino acid motifs, comprised of two amino
acids each, were expressed in higher proportions (statistically significant) in the CDR3 of sev-
eral T-cell clones from AAA lesions in a number of patients vs. those of PBMC from normal
donors, used as methodological controls (Table 5). These CDR3 two amino acid motifs, may
be coded by nontemplated nucleotides, (see above, [74]), and may have undergone selection
by antigenic stimulation. Preferential Vβ22 and Vβ25 utilization was found [83] in aneurysmic
lesions from 10 of 14 patients with Marfan Syndrome, familial thoracic aortic aneurisms
(TAAs) and patients with sporadic TAAs.
We studied here TCR transcripts from fresh (uncultured) T cells, and not T cells expanded
in vitro, in culture with recombinant IL-2 (rIL-2). T-cell lines expanded in culture with rIL-2
are comprised of different proportions of T-cell clones vs. those present in fresh, uncultured, T
cells from the same donor, and exhibit different properties such as cytokine production [84].
Growth rates of different T-cell clones in culture with rIL-2 are often different. Expansion of T
cells in different concentrations of rIL-2 yields T-cell lines with quite different properties [85].
The αβ TCR+ T-cell repertoire is very large [44–46,62,63] and the maximum theoretical
number is 1018 different α/β TCR, 107 α-chain, and 1012 β-chain TCR transcripts [62]. Each
T-cell clone is identified by a unique TCR and recognizes a different antigenic epitope (peptide
plus MHC) through its TCR, which is the unique fingerprint of that particular T-cell clone.
The number of T-cell clones is greatly reduced during thymic selection and only a small pro-
portion survive and become mature T cells. Arstila et al [44] estimated that 1x106 different β-
chain TCR transcripts may be expressed in different T-cell clones in PBMC of normal donors.
Each one of them may be pairing with 25 or more different α-chain TCR [44]. Warren et al
[63] used high-throughput sequencing of β-chain TCR to measure at least 1x106 distinct β-
chain TCR in PBMC. Robins et al [45] used deep sequencing and a Poisson statistical model to
estimate 3-4x106 β-chain TCR sequences in the peripheral blood, a 4-fold higher than the
other two estimates. Qi et al [46] employed next-generation sequencing and non-parametric
statistics to estimate the size of the β-chain TCR repertoire to be 100x106 β-chain TCR
sequences in the peripheral blood. The size of the T-cell repertoire is very large and the num-
ber of different T-cell clones is very high and able to recognize all conceivable antigenic epi-
topes. Therefore, the probability is very small of finding by chance two or multiple identical α-
or β-chain TCR transcripts in an independent sample of T cells. The presence of multiple iden-
tical copies of α- or β-chain TCR transcripts has to be the result of specific antigen-driven pro-
liferation and clonal expansion of particular T-cell clone(s) in vivo in AAA lesions, in response
to as yet unidentified antigen(s), self or non-self, that they recognize.
Several lines of evidence (Table 1), strongly suggest that autoimmunity may be responsible
for the pathogenesis of AAA, which may be an autoimmune disease [3–5, 9–41]. The identifi-
cation of the three components of the trimolecular complex in AAA, and in particular the
clonal expansions of the α- and β-chain TCR of T cells in AAA lesions ([10, 41], and this
study), the association of AAA with MHC Class I and II [20–22] and the identification of
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putative AAA antigens [23–36], provide a compelling argument that AAA is a specific anti-
gen-driven T-cell disease. AAA formation is controlled by cells, cytokines, and small molecules
that inhibit inflammation (Table 1, [86]). Impaired immunoregulation may also play a role
[38–40]. Chronic inflammation mechanisms in AAA are typical to those in autoimmune dis-
ease [87] and the immune response to tumors [88]. However, formation of transient follicles
has been observed during the destabilization of atherosclerotic plaques [89] and it could be
suggested that such a mechanism may be responsible for the presence of mononuclear cell
infiltrates in AAA lesions and that the immune response identified in AAA may be secondary
in the disease process. However, others emphasize the differences between AAA and athero-
sclerosis and the increasingly popular view of the autoimmune hypothesis as responsible for
the etiology of AAA versus the atherogenic theory [90]. Nevertheless, our understanding of the
pathogenesis of AAA is still limited.
AAA is associated with certain HLA class I (HLA-A2, HLA-B61) and class II
(HLA-DerRB1�02, -DRB1�04) alleles [20–22,35]. Three (AAA03, AAA09 and AAA10) of the 5
patients studied here were typed by DNA-based HLA-typing approaches and had DRB1 alleles
positive for the DRβGln70 amino acid residue (Table 4). These 3 patients exhibited in AAA
lesions statistically significant clonal expansions of both α- and β-chain TCR transcripts.
DNA-based HLA-typing of 6 patients with AAA [41], including the 3 patients shown here,
revealed the expression of the DRβGln70 amino acid residue in 5 of 6 patients [41]. Clonally
expanded β-chain TCR transcripts were found in 5 of these 6 patients and 4 expressed
DRβGln70 [41]. The DRβGln70 amino acid residue is associated with AAA [21, 22] and it
forms together with amino acid residues in positions 67, 71 and 74 a binding peptide pocket
(#4) in HLA-DRB1 [91,92], which is associated with certain autoimmune disorders [91–93]. A
large number of DRB1 alleles with Gln at position 70 of the β-chain have been identified [55].
Our studies demonstrate clonally expanded αβ TCR in AAA lesions and may permit identi-
fication of the three molecular components of the trimolecular complex, the αβ TCR, the
HLA-DRβGln[70](and perhaps other HLA epitopes) and the AAA-associated antigens (pep-
tides), self [3,18,19,23–26,30] and non-self [31–36], responsible for the immunopathogenesis
of the disease. These antigens may be involved in the immunopathogenesis of AAA and in par-
ticular the initiation and/or the propagation of the disease. Molecular mimicry [37], which is
defined as the sharing of cross-reactive antigenic determinants between host antigens and
microorganisms, including viruses or bacteria, may be involved in the pathogenesis of AAA
[35]. AAA may be initiated by an immune response to a virus or bacterium, which may cross-
react with an antigenic epitope of a self-antigen, by molecular mimicry. After the clearance of
the microorganism, the initial immune response may be propagated by the crossreactive anti-
genic epitope(s) of a self-antigen [37]. Molecular mimicry may be more likely responsible for
the pathogenesis of the disease than purely autoreactive T cell clones. T cells with high affinity
for self-antigenic determinants would have been eliminated during thymic selection. In con-
trast, T cell clones that recognize crossreactive antigenic determinants of host antigens and
microorganisms may escape elimination during thymic selection. In addition to intiation,
propagation/progression is very important for the development of clinical disease. The evi-
dence suggesting that the immune system is responsible for propagation/progression of the
disease is strong and it is further supported by the unique ability of the immune system to
exhibit immunological memory.
Our results (this report and [10,41]) provide strong evidence supporting the hypothesis that
AAA is a specific antigen-driven T cell disease. The identification of the clonally-expanded
TCR transcripts in AAA lesions, may permit the identification of the antigens, self or nonself,
recognized by the clonally expanded T lymphocytes. These AAA-associated antigens may play
a critical role in the initiation and/or the propagation of the disease, and identification of their
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role is critical for understanding AAA and may permit the development of new therapies for
the management of aneurismal disease.
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